Published in Oncotarget on February 28, 2017
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell (2006) 21.66
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
Roles of TGFbeta in metastasis. Cell Res (2009) 4.35
TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell (2010) 3.69
A multigene predictor of outcome in glioblastoma. Neuro Oncol (2009) 3.57
High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell (2007) 3.27
Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell (2013) 2.98
TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol (2013) 2.80
Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell (2009) 2.79
Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia (2011) 2.32
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res (2005) 1.81
Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res (2009) 1.61
Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. Curr Opin Cell Biol (2014) 1.55
Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro Oncol (2009) 1.51
Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR. J Neurooncol (2008) 1.40
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res (2005) 1.37
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation. Cell Signal (2013) 1.35
TGF-β as a therapeutic target in high grade gliomas - promises and challenges. Biochem Pharmacol (2012) 1.33
Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol (2001) 1.33
Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family. Gene (1996) 1.21
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest (2013) 1.19
SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. Cancer Res (2003) 1.18
Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J Biol Chem (2002) 1.17
Targeting TGF-β signaling in cancer. Expert Opin Ther Targets (2013) 1.16
TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta. Biochim Biophys Acta (2009) 1.16
TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin Cancer Biol (2012) 1.13
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma. Clin Cancer Res (2014) 1.09
Tumor-promoting functions of transforming growth factor-β in progression of cancer. Ups J Med Sci (2011) 1.06
Genomic estimates of aneuploid content in glioblastoma multiforme and improved classification. Clin Cancer Res (2012) 1.06
Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins. Gene (1996) 1.06
CD44 in human glioma correlates with histopathological grade and cell migration. Pathol Int (2012) 1.04
TGF beta signaling and its role in glioma pathogenesis. Adv Exp Med Biol (2013) 1.00
A hierarchical approach employing metabolic and gene expression profiles to identify the pathways that confer cytotoxicity in HepG2 cells. BMC Syst Biol (2007) 0.98
Role of TGF-β and the tumor microenvironment during mammary tumorigenesis. Gene Expr (2011) 0.97
Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22. Genomics (1998) 0.95
TGF-β signaling and its targeting for glioma treatment. Am J Cancer Res (2015) 0.93
DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas. Brain Pathol (2007) 0.91
TGF-beta signaling in cancer treatment. Curr Pharm Des (2014) 0.90
EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q. Int J Cancer (2007) 0.87
Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma. Endocr Relat Cancer (2008) 0.85
EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma. Cancer Lett (2008) 0.83
Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes. J Transl Med (2009) 0.82
Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. Exp Mol Pathol (2013) 0.81
TGF-β/Smad2/3 signal pathway involves in U251 cell proliferation and apoptosis. Gene (2015) 0.81
PTK7 regulates Id1 expression in CD44-high glioma cells. Neuro Oncol (2014) 0.81
Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression. Asian Pac J Cancer Prev (2015) 0.79
Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas. Biomed Res Int (2013) 0.79
Potential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway. J Urol (2013) 0.79
Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma. Mol Med Rep (2015) 0.79
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway. Oncotarget (2015) 0.78
EMP3 as a candidate tumor suppressor gene for solid tumors. Expert Opin Ther Targets (2009) 0.78